Effects of physiological electric fields on migration of human dermal fibroblasts.
Endogenous electric currents generated instantly at skin wounds direct migration of epithelial cells and are likely to be important in wound healing. Migration of fibroblasts is critical in wound healing. It remains unclear how wound electric fields guide migration of dermal fibroblasts. We report here that mouse skin wounds generated endogenous electric currents for many hours. Human dermal fibroblasts of both primary and cell-line cultures migrated directionally but slowly toward the anode in an electric field of 50-100 mV mm(-1). This is different from keratinocytes, which migrate quickly to the cathode. It took more than 1 hour for dermal fibroblasts to manifest detectable directional migration. Larger field strength (400 mV mm(-1)) was required to induce directional migration within 1 hour after onset of the field. Phosphatidylinositol-3-OH kinase (PI3 kinase) mediates cathode-directed migration of keratinocytes. We tested the role of PI3 kinase in anode-directed migration of fibroblasts. An applied electric field activated PI3 kinase/Akt in dermal fibroblasts. Dermal fibroblasts from p110gamma (a PI3 kinase catalytic subunit) null mice showed significantly decreased directional migration. These results suggest that physiological electric fields may regulate motility of dermal fibroblasts and keratinocytes differently, albeit using similar PI3 kinase-dependent mechanisms.
Guo
Aihua
A
School of Medical Sciences, University of Aberdeen, Aberdeen, Scotland, UK.
Song
Bing
B
Reid
Brian
B
Gu
Yu
Y
Forrester
John V
JV
Jahoda
Colin A B
CA
Zhao
Min
M
D000818:Animals; D002460:Cell Line; D002465:Cell Movement / Q000502:physiology*; D058534:Class I Phosphatidylinositol 3-Kinases; D020405:Dermis / Q000166:cytology; D004307:Dose-Response Relationship, Radiation; D004574:Electromagnetic Fields; D005347:Fibroblasts / Q000166:cytology* / Q000528:radiation effects*; D006801:Humans; D015603:Keratinocytes / Q000166:cytology* / Q000528:radiation effects*; D051379:Mice; D008810:Mice, Inbred C57BL; D008817:Mice, Mutant Strains; D019869:Phosphatidylinositol 3-Kinases / Q000235:genetics / Q000378:metabolism; D051057:Proto-Oncogene Proteins c-akt / Q000378:metabolism; D015398:Signal Transduction / Q000528:radiation effects; D014945:Wound Healing / Q000502:physiology
D019869:Phosphatidylinositol 3-Kinases; C509622:1-phosphatidylinositol 3-kinase p110 subunit, mouse; D058534:Class I Phosphatidylinositol 3-Kinases; D051057:Proto-Oncogene Proteins c-akt
Adv Wound Care. 1996 Sep-Oct;9(5):42-5
9069747
Mol Biol Cell. 2006 Nov;17(11):4925-35
16914518
Conf Proc IEEE Eng Med Biol Soc. 2006;2006:4326-8
17947077
Dermatol Clin. 1993 Oct;11(4):775-81
8222361
Bioessays. 2003 Aug;25(8):759-66
12879446
Nature. 2006 Jul 27;442(7101):457-60
16871217
Arterioscler Thromb Vasc Biol. 2004 Jul;24(7):1234-9
15130919
Connect Tissue Res. 2007;48(4):188-97
17653975
J Am Acad Dermatol. 1991 Dec;25(6 Pt 1):1054-8
1810982
Ophthalmic Res. 2007;39(1):4-16
17164572
Bioessays. 1997 Sep;19(9):819-26
9297973
Front Biosci. 2004 Jan 01;9:283-9
14766366
J Burn Care Rehabil. 1993 May-Jun;14(3):319-35
8360237
FASEB J. 2005 Mar;19(3):379-86
15746181
Nature. 2008 May 15;453(7193):314-21
18480812
Cell Motil Cytoskeleton. 1991;19(2):121-33
1878979
Cochrane Database Syst Rev. 2006 Apr 19;(2):CD002930
16625564
Lancet. 2005 Nov 12;366(9498):1736-43
16291068
Nat Protoc. 2007;2(3):661-9
17406628
Exp Dermatol. 2003 Aug;12(4):396-402
12930295
J Cell Sci. 1996 Jan;109 ( Pt 1):199-207
8834804
N Engl J Med. 1999 Sep 2;341(10):738-46
10471461
Semin Cell Dev Biol. 2009 Aug;20(6):674-82
19146969
Physiol Rev. 2005 Jul;85(3):943-78
15987799
Br J Dermatol. 1983 Nov;109(5):515-22
6639877
Biophys J. 2000 Jul;79(1):144-52
10866943
Proc Natl Acad Sci U S A. 2002 Oct 15;99(21):13577-82
12368473
Invest Ophthalmol Vis Sci. 1990 Nov;31(11):2278-82
2242993
J Cell Biol. 1985 Dec;101(6):2023-7
3905820
Wound Repair Regen. 2008 Sep-Oct;16(5):585-601
19128254
J Physiol. 1972 Oct;226(2):407-29
4538944
J Cell Biol. 2006 Mar 27;172(7):1093-105
16549496
J Invest Dermatol. 1998 Nov;111(5):751-6
9804333
J Cell Sci. 2005 Mar 15;118(Pt 6):1117-28
15728257
FASEB J. 2002 Aug;16(10):1195-204
12153987
J Cell Sci. 2004 Sep 15;117(Pt 20):4681-90
15371524
Exp Eye Res. 2000 May;70(5):667-73
10870525
Wound Repair Regen. 2008 May-Jun;16(3):432-41
18471262
J Exp Zool. 1979 Jul;209(1):49-56
314968
J Cell Sci. 2004 Mar 15;117(Pt 8):1533-45
15020680
Phys Ther. 1988 Apr;68(4):503-8
3258429
J Cell Biol. 1994 Oct;127(1):117-28
7929557
Clin Dermatol. 1984 Jul-Sep;2(3):34-44
6336255
Exp Eye Res. 1992 Jun;54(6):999-1003
1521590
Am J Physiol. 1982 Mar;242(3):R358-66
7065232
Curr Top Dev Biol. 2003;58:1-26
14711011
Science. 1997 Apr 4;276(5309):75-81
9082989
J Cell Sci. 1996 Jun;109 ( Pt 6):1405-14
8799828
J Cell Biol. 1984 Jan;98(1):296-307
6707093
Lancet. 2003 Feb 15;361(9357):574-6
12598145
Arch Dermatol. 1990 Feb;126(2):222-5
2405781
Exp Cell Res. 1983 Aug;147(1):195-201
6617761
Mol Biol Cell. 2004 Jan;15(1):294-309
14595114
Physiol Rev. 2003 Jul;83(3):835-70
12843410